Search - tctmd.com

Displaying 21 - 40 of 100

Sort: Relevancy | Date

News Conference News ACC 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Michael O'Riordan

April 01, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

Presentation JIM 2018

Case: 57-year old man with known Alport syndrome: dialysis from age 17-years

Presenter: Azeem Latib

February 21, 2018

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Shelley Wood

March 06, 2017

News Daily News

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

Yael L. Maxwell

September 02, 2016

Presentation TVT 2016

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Presenter: Ganesh Manoharan

June 17, 2016

Presentation SOLACI 2016

Denervación Renal - Donde estamos hoy?

Presenter: Humberto Casal Pati?o

June 10, 2016

News Daily News

Renal Denervation Trials Have Largely Fallen Victim to Unintentional Bias

Todd Neale

January 19, 2016

News Daily News

Los Ensayos de Denervación Renal Han Sido Víctimas de Sesgos Involuntarios

Todd Neale

January 19, 2016

News Daily News

Desarrollan una Calculadora para Predecir el Riesgo de LRA Post-Angiografía en una Población de Veteranos

Caitlin E. Cox

December 29, 2015

News Daily News

Calculator Developed to Predict AKI Risk After Angiography in VA Population

Caitlin E. Cox

December 29, 2015

News Conference News TCT 2015

SYMPLICITY HTN-3 Results Continue to Spur Discussion

October 11, 2015

News Daily News

血流动力学抑制与肾脏疾病患者行 CAS 后的肾损伤相关

L.A. McKeown

September 28, 2015

News Daily News

La Depresión Hemodinámica se asoció a la Lesión Renal Post-CAS en Pacientes con Enfermedad Renal

L.A. McKeown

September 28, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

Presentation

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

Presenter: M. Donahue

September 25, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

September 22, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

Advertisement

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Case: 57-year old man with known Alport syndrome: dialysis from age 17-years

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Denervación Renal - Donde estamos hoy?

Renal Denervation Trials Have Largely Fallen Victim to Unintentional Bias

Los Ensayos de Denervación Renal Han Sido Víctimas de Sesgos Involuntarios

Desarrollan una Calculadora para Predecir el Riesgo de LRA Post-Angiografía en una Población de Veteranos

Calculator Developed to Predict AKI Risk After Angiography in VA Population

SYMPLICITY HTN-3 Results Continue to Spur Discussion

血流动力学抑制与肾脏疾病患者行 CAS 后的肾损伤相关

La Depresión Hemodinámica se asoció a la Lesión Renal Post-CAS en Pacientes con Enfermedad Renal

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content